CNS/Brain Cancer
Feature
Convenience, not outcomes may drive robot-assisted surgeries
The sale of robotically assisted surgical devices is expected to reach $14 billion by 2028. The technology is enticing to both surgeons and...
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
From the Journals
Novel virus targeting deadly brain tumors shows early promise
"To my knowledge, this is the first time neural stem cells have been used as a delivery strategy for an oncolytic virus," Dr. Terence Burns said...
Conference Coverage
Combo treatment for NSCLC with brain metastases extends survival by two years for some
The progression-free survival findings are similar to those of a related trial that also showed improved outcomes with pembrolizumab plus...
Latest News
One in three cancer articles on social media has wrong info
Physician says misleading information online may be harmful to patients.
Latest News
More children with high-risk brain cancer now surviving
Conference Coverage
‘Remarkable’ results for targeted therapy of rare CNS tumors
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
Clinical Insights
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Conference Coverage
Deadly brain tumor: Survival extended by oncolytic virus product
Improved survival was seen in a small trial in which a genetically engineered version of herpes simplex virus was infused directly into high-grade...
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...